Ubs Global Asset Management Americas »

Bridgebio Pharma shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $45M 53M 0.85
2023-09-30 $40M 53M 0.76

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Amazon Equity Us Cm (AMZN)
Nvidia Corp Equity Us Cm (NVDA)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Tesla Equity Us Cm (TSLA)
Meta Platforms Equity Us Cm (META)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Unitedhealth Group Equity Us Cm (UNH)
Broadcom Equity Us Cm (AVGO)
Adobe Equity Us Cm (ADBE)
Eli Lilly &#38 Equity Us Cm (LLY)
Visa Inc Class A Shares Equity Us Cm (V)
Home Depot Equity Us Cm (HD)
Johnson &#38 Johnson Equity Us Cm (JNJ)

View all positions for Ubs Global Asset Management Americas

Top funds holding Bridgebio Pharma

Braidwell
Ubs Global Asset Management Americas
D. E. Shaw & Co
Weiss Asset Management LP[1
Aristeia Capital
Context Capital Management
Laurion Capital Management
Point72 Asset Management
DeepCurrents Investment Group
Diameter Capital Partners
Wells Fargo & Company
Aequim Alternative Investments
Segantii Capital Management
Calamos Advisors
Lord, Abbett & Co

View all funds holding Bridgebio Pharma